Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes, has become one of the most studied medications for weight management in the last decade. Clinical data from the STEP trials demonstrated that adults on semaglutide lost an average of 15-18% of their body weight over 68 weeks, compared to 2-3% in the placebo group. Like all medications, semaglutide carries both documented benefits and potential side effects that deserve careful consideration before treatment begins.

How Semaglutide Works in the Body

Semaglutide mimics a natural hormone called GLP-1, which your pancreas releases after eating. This hormone signals your brain that you feel full, slows digestion, and reduces your appetite for several hours. By activating GLP-1 receptors throughout your body, semaglutide amplifies these signals, helping you eat less and feel satisfied with smaller portions. The medication also stabilizes blood sugar levels, which reduces hunger-driven energy crashes that often trigger overeating.

The drug works gradually—your body adjusts to the medication over time, which is why starting with a low dose and increasing slowly is standard practice. Most people begin at 0.25 mg per week and may increase to 2.4 mg weekly depending on individual tolerance and clinical goals. This titration approach minimizes gastrointestinal side effects while allowing your metabolism to adapt to reduced calorie intake.

Documented Benefits Based on Clinical Evidence

The STEP 1 trial followed 1,961 adults with obesity for 68 weeks and found that semaglutide produced an average weight loss of 15.3 kg (33.7 lbs) at the 2.4 mg dose, compared to 2.6 kg in the placebo group. Beyond weight reduction, participants showed improvements in cardiovascular risk factors including lower blood pressure, reduced triglycerides, and improved cholesterol profiles. A separate cardiovascular outcomes trial demonstrated that semaglutide reduced the risk of major adverse cardiac events by 26% in people with established heart disease, suggesting benefits extend beyond weight alone.

Many patients report improvements in joint pain, sleep quality, and energy levels as weight decreases. Type 2 diabetes remission rates reached 74% in some trial cohorts, and metabolic improvements often occur before significant weight loss is visible on the scale. These systemic benefits reflect how excess weight contributes to inflammation and metabolic dysfunction throughout the body.

Common Side Effects and Safety Considerations

Gastrointestinal effects represent the most frequently reported side effects, occurring in 25-50% of users depending on dose and individual sensitivity. Nausea, vomiting, diarrhea, and constipation typically peak during dose increases and often improve within 1-2 weeks as your body adjusts. These effects are usually mild to moderate and manageable through dietary modifications like eating smaller, lower-fat meals and staying well-hydrated. Serious gastrointestinal complications like pancreatitis are rare but have been documented, making it critical to report severe abdominal pain immediately to your healthcare provider.

Dehydration can occur due to nausea and vomiting, so maintaining adequate fluid and electrolyte intake is essential. Some users experience dizziness, fatigue, or headaches, particularly during the first two weeks of treatment or after dose increases. Rare but serious risks include thyroid tumors (based on animal studies), gallbladder disease, and diabetic retinopathy progression in people with existing diabetes. Anyone with a personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome should not use semaglutide.

How Genetic Testing Personalizes Your Semaglutide Response

Not everyone responds to semaglutide the same way—genetic variation in your GLP-1 receptor, GIPR receptor, FTO gene, and MC4R gene significantly influences how well the medication works for you. PlexusDx's Precision Peptide Genetic Test identifies your specific genetic predispositions across 14 metabolic pathways and 49 peptide systems, revealing whether you're a responder, partial responder, or non-responder to GLP-1 therapy. This information guides dosing strategy, helps predict side effect likelihood, and determines whether semaglutide or an alternative like tirzepatide might be more effective for your unique biology.

The test examines key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—all of which correlate with weight loss outcomes in published research. By understanding your genetic profile before starting treatment, you can optimize your therapy approach and avoid months of trial-and-error with ineffective medications. PlexusDx offers this genetic test for $99 as an add-on after your first month of treatment, enabling personalized precision medicine.

PlexusDx Semaglutide: Access, Pricing, and Safety Standards

PlexusDx compounded semaglutide injection starts at $149 per month across all dose levels—your dose may need to go up, but your price won't. The medication is prepared by licensed 503A compounding pharmacies, which operate under strict U.S. Pharmacopeia standards and FDA oversight to ensure pharmaceutical-grade purity and potency. PlexusDx serves all 50 states without requiring insurance or memberships, and treatment is HSA/FSA eligible for patients with qualified accounts. This accessibility model removes financial barriers that often prevent people from accessing evidence-based weight loss therapy.

All compounded semaglutide undergoes sterility testing, potency verification, and identity confirmation before shipment to ensure safety equivalent to branded versions. Unlike 503B bulk manufacturing, 503A compounding allows for individualized preparation tailored to your specific needs. PlexusDx also offers oral semaglutide at $249 per month for patients who prefer non-injection therapy, providing flexibility in treatment modality while maintaining clinical efficacy and safety standards.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is semaglutide safe for long-term weight loss use?

Yes—semaglutide has demonstrated safety in clinical trials lasting up to 3 years, with the most common side effects (nausea and gastrointestinal symptoms) typically diminishing after the first month of treatment. Serious adverse events occur in less than 5% of users and are usually manageable with dose adjustment or discontinuation.

How much weight can I expect to lose on semaglutide?

The STEP clinical trials demonstrated average weight loss of 15-18% of body weight at the highest dose over 68 weeks, though individual results vary based on genetics, lifestyle adherence, and baseline metabolic health. Someone weighing 250 pounds might lose 37-45 pounds, while another person might lose 20-25 pounds with the same dose.

What is the cost of PlexusDx semaglutide treatment?

PlexusDx compounded semaglutide injection starts at $149 per month and remains $149 throughout your treatment regardless of dose increases—your dose may need to go up, but your price won't. Oral semaglutide costs $249 per month flat-rate.

Are there serious side effects I should know about?

Serious side effects are rare but include acute pancreatitis (severe abdominal pain), gallbladder disease, and diabetic retinopathy worsening in people with diabetes. Dehydration from nausea can lead to electrolyte imbalances if fluid intake isn't maintained.

How does genetic testing help with semaglutide therapy?

PlexusDx's Precision Peptide Genetic Test identifies variants in your GLP1R, GIPR, FTO, and MC4R genes that predict your individual semaglutide response—whether you'll be a strong responder, partial responder, or non-responder.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves